Schonfeld Strategic Advisors’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-149,996
| Closed | -$423K | – | 2342 |
|
|
2025
Q1 | $423K | Buy |
149,996
+26,796
| +22% | +$75.6K | ﹤0.01% | 1529 |
|
|
2024
Q4 | $848K | Sell |
123,200
-42,800
| -26% | -$294K | ﹤0.01% | 1126 |
|
|
2024
Q3 | $3.02M | Buy |
166,000
+90,963
| +121% | +$1.65M | 0.02% | 608 |
|
|
2024
Q2 | $1.43M | Sell |
75,037
-57,963
| -44% | -$1.1M | 0.01% | 934 |
|
|
2024
Q1 | $2.87M | Buy |
133,000
+83,800
| +170% | +$1.81M | 0.02% | 713 |
|
|
2023
Q4 | $855K | Buy |
49,200
+2,800
| +6% | +$48.6K | 0.01% | 1017 |
|
|
2023
Q3 | $456K | Sell |
46,400
-600
| -1% | -$5.89K | ﹤0.01% | 1104 |
|
|
2023
Q2 | $259K | Buy |
47,000
+5,900
| +14% | +$32.5K | ﹤0.01% | 1398 |
|
|
2023
Q1 | $255K | Buy |
41,100
+11,600
| +39% | +$71.9K | ﹤0.01% | 1414 |
|
|
2022
Q4 | $450K | Buy |
+29,500
| New | +$450K | ﹤0.01% | 1571 |
|